Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tayla Stenta"'
Autor:
Tayla Stenta, Michael Assis, Katie Ayers, Elena J. Tucker, Andreas Halman, Debra Gook, Andrew H. Sinclair, David A. Elliott, Yasmin Jayasinghe, Rachel Conyers
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 6, Pp n/a-n/a (2024)
Abstract For the same age, sex, and dosage, there can be significant variation in fertility outcomes in childhood cancer survivors. Genetics may explain this variation. This study aims to: (i) review the genetic contributions to infertility, (ii) sea
Externí odkaz:
https://doaj.org/article/9da17279edc8498091a0ed9babfda7ca
Autor:
Tim Spelman, Elizabeth Williams, Rishi S Kotecha, Rachel Conyers, Andreas Halman, Claire Moore, Tayla Stenta, Ben Felmingham, Lane Collier, Dhrita Khatri, Roxanne Dyas, Sophie Jessop, Marion K Mateos, Jesse Swen, David A Elliott
Publikováno v:
BMJ Open, Vol 14, Iss 5 (2024)
Introduction DNA-informed prescribing (termed pharmacogenomics, PGx) is the epitome of personalised medicine. Despite international guidelines existing, its implementation in paediatric oncology remains sparse.Methods and analysis Minimising Adverse
Externí odkaz:
https://doaj.org/article/4da7ddc3784e4dbca556abc4b8bf9c7f
Autor:
Claire Moore, Smaro Lazarakis, Tayla Stenta, Marliese Alexander, Rachel Phan Nguyen, David A. Elliott, Rachel Conyers
Publikováno v:
Pharmacology Research & Perspectives, Vol 11, Iss 6, Pp n/a-n/a (2023)
Abstract Pharmacogenomics remains underutilized in clinical practice, despite the existence of internationally recognized, evidence‐based guidelines. This systematic review aims to understand enablers and barriers to pharmacogenomics implementation
Externí odkaz:
https://doaj.org/article/59406886247f4b3a9c5c01e1927d4588
Autor:
Yudha Nur Patria, Tayla Stenta, Jinia Lilianty, Lynn Rowley, Edouard G. Stanley, Andrew G. Elefanty, John F. Bateman, Shireen R. Lamandé
Publikováno v:
Stem Cell Research, Vol 48, Iss , Pp 101942- (2020)
To produce in vitro models of human chondrodysplasias caused by dominant missense mutations in TRPV4, we used CRISPR/Cas9 gene editing to introduce two heterozygous patient mutations (p.F273L and p.P799L) into an established control human iPSC line.
Externí odkaz:
https://doaj.org/article/1b30b9d66478485f850dcb65bca8ce26
Autor:
Shireen R. Lamandé, Elizabeth S. Ng, Trevor L. Cameron, Louise H. W. Kung, Lisa Sampurno, Lynn Rowley, Jinia Lilianty, Yudha Nur Patria, Tayla Stenta, Eric Hanssen, Katrina M. Bell, Ritika Saxena, Kathryn S. Stok, Edouard G. Stanley, Andrew G. Elefanty, John F. Bateman
Publikováno v:
Proceedings of the National Academy of Sciences. 120
Chondrocytes and osteoblasts differentiated from induced pluripotent stem cells (iPSCs) will provide insights into skeletal development and genetic skeletal disorders and will generate cells for regenerative medicine applications. Here, we describe a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f44005e5885c5223c651c0ebe78aa93d
https://doi.org/10.1073/pnas.2211510120
https://doi.org/10.1073/pnas.2211510120
Autor:
John F. Bateman, Shireen R. Lamandé, Jinia Lilianty, Lynn Rowley, Edouard G. Stanley, Tayla Stenta, Yudha Nur Patria, Andrew G. Elefanty
Publikováno v:
Stem Cell Research, Vol 48, Iss, Pp 101942-(2020)
To produce in vitro models of human chondrodysplasias caused by dominant missense mutations in TRPV4, we used CRISPR/Cas9 gene editing to introduce two heterozygous patient mutations (p.F273L and p.P799L) into an established control human iPSC line.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20b4294962a27febd22e257c0f4cb452
https://pubmed.ncbi.nlm.nih.gov/32771907
https://pubmed.ncbi.nlm.nih.gov/32771907